Pifeltro is an antiviral medicine used to treat adults and adolescents from 12 years of age weighing at least 35 kg who are infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS). Pifeltro is used together with other antiviral medicines. It is only used in patients where the virus has not developed resistance to medicines that work in the same way as Pifeltro. Pifeltro contains the active substance doravirine.
Therapeutic Indication
### Therapeutic indication Pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with HIV 1 without past or present evidence of resistance to the NNRTI class.
Therapeutic Area (MeSH)
N/AATC Code
J05AG06
ATC Item
doravirine
Pharmacotherapeutic Group
Antivirals for systemic use
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| doravirine | N/A | 多拉韦林 |
EMA Name
Pifeltro
Medicine Name
Pifeltro
Aliases
N/ANo risk management plan link.
